Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-12-101186
Filing Date
2012-03-07
Accepted
2012-03-07 16:06:35
Documents
15
Period of Report
2011-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d276649d10k.htm 10-K 1023524
2 SUBSIDIARIES OF FURIEX PHARMACEUTICALS, INC. d276649dex211.htm EX-21.1 2054
3 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM d276649dex231.htm EX-23.1 1890
4 CERTIFICATION BY THE PRINCIPAL EXECUTIVE OFFICER PURSUANT TO SECTION 302 d276649dex311.htm EX-31.1 6536
5 CERTIFICATION BY THE PRINCIPAL FINANCIAL OFFICER PURSUANT TO SECTION 302 d276649dex312.htm EX-31.2 6587
6 CERTIFICATION BY THE PRINCIPAL EXECUTIVE OFFICER PURSUANT TO SECTION 906 d276649dex321.htm EX-32.1 3180
7 CERTIFICATION BY THE PRINCIPAL FINANCIAL OFFICER PURSUANT TO SECTION 906 d276649dex322.htm EX-32.2 3300
14 GRAPHIC g276649g03f69.jpg GRAPHIC 42826
15 GRAPHIC g276649xbrl_tx-05.jpg GRAPHIC 125257
  Complete submission text file 0001193125-12-101186.txt   3768724

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT furx-20111231.xml EX-101.INS 518728
9 XBRL TAXONOMY EXTENSION SCHEMA furx-20111231.xsd EX-101.SCH 14948
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE furx-20111231_cal.xml EX-101.CAL 36021
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE furx-20111231_def.xml EX-101.DEF 10439
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE furx-20111231_lab.xml EX-101.LAB 135911
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE furx-20111231_pre.xml EX-101.PRE 91227
Mailing Address 3900 PARAMOUNT PARKWAY SUITE 150 MORRISVILLE NC 27560
Business Address 3900 PARAMOUNT PARKWAY SUITE 150 MORRISVILLE NC 27560 919-456-7800
Furiex Pharmaceuticals, Inc. (Filer) CIK: 0001484478 (see all company filings)

EIN.: 271197863 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-34641 | Film No.: 12674286
SIC: 2834 Pharmaceutical Preparations